Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bolt Biotherapeutics Q4 EPS $(0.47) Beats $(0.48) Estimate, Sales $2.09M Beat $1.71M Estimate

Author: Happy Mohamed | March 21, 2024 04:20pm
Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 11.32 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $2.09 million which beat the analyst consensus estimate of $1.71 million by 22.16 percent. This is a 48.05 percent increase over sales of $1.41 million the same period last year.

Posted In: BOLT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist